Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

CLVLY

Clinuvel Pharmaceuticals Limited

USD

Set alert

Price alert · CLVLY

All alert types
6.74 USD 0.00 0.00%
As of Aug 10, 2026
6.74 Day range 6.74
5.98 52-week range 9.00
YTD
-20.52%
1 year
-3.44%
Open
6.74
Prev close
6.74
Mkt cap
339.88M
Vol
152
Avg vol
3.00K
EPS
0.465
P/E
14.49
More statistics
Low
6.74
High
6.74

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for CLVLY has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

16.35 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 14.3×
FY 2016: -63.4×FY 2017: 46.7×FY 2018: 39.4×FY 2019: 86.4×FY 2020: 82.0×FY 2021: 60.9×FY 2022: 35.4×FY 2023: 29.0×FY 2024: 20.5×FY 2025: 14.3×
FY 2016 5y median 29.0× FY 2025
P/S 5.4×
FY 2016: 29.0×FY 2017: 19.9×FY 2018: 20.7×FY 2019: 51.0×FY 2020: 38.5×FY 2021: 31.4×FY 2022: 11.2×FY 2023: 11.3×FY 2024: 8.3×FY 2025: 5.4×
FY 2016 5y median 11.2× FY 2025
P/B 2.1×
FY 2016: 11.1×FY 2017: 13.2×FY 2018: 13.4×FY 2019: 27.7×FY 2020: 17.4×FY 2021: 15.2×FY 2022: 5.9×FY 2023: 5.4×FY 2024: 3.6×FY 2025: 2.1×
FY 2016 5y median 5.4× FY 2025
P/FCF 12.7×
FY 2016: -38.5×FY 2017: 33.9×FY 2018: 45.3×FY 2019: 87.0×FY 2020: 94.2×FY 2021: 81.8×FY 2022: 18.6×FY 2023: 24.8×FY 2024: 23.3×FY 2025: 12.7×
FY 2016 5y median 23.3× FY 2025
EV/EBITDA 5.1×
FY 2016: -44.2×FY 2017: 45.3×FY 2018: 40.0×FY 2019: 91.1×FY 2020: 115×FY 2021: 52.1×FY 2022: 20.9×FY 2023: 20.8×FY 2024: 9.8×FY 2025: 5.1×
FY 2016 5y median 20.8× FY 2025
EV/Sales 3.1×
FY 2016: 27.0×FY 2017: 18.5×FY 2018: 19.2×FY 2019: 49.2×FY 2020: 37.7×FY 2021: 30.6×FY 2022: 10.8×FY 2023: 11.1×FY 2024: 6.3×FY 2025: 3.1×
FY 2016 5y median 10.8× FY 2025
FCF Yield 7.9%
FY 2016: -2.6%FY 2017: 2.9%FY 2018: 2.2%FY 2019: 1.1%FY 2020: 1.1%FY 2021: 1.2%FY 2022: 5.4%FY 2023: 4.0%FY 2024: 4.3%FY 2025: 7.9%
FY 2016 5y median 4.3% FY 2025

Profitability

Gross Margin 83.3%
FY 2016: 71.6%FY 2017: 96.3%FY 2018: 96.3%FY 2019: 98.6%FY 2020: 56.6%FY 2021: 73.4%FY 2022: 70.9%FY 2023: 64.6%FY 2024: 91.2%FY 2025: 83.3%
FY 2016 5y median 73.4% FY 2025
Operating Margin 48.1%
FY 2016: -52.0%FY 2017: 40.6%FY 2018: 47.9%FY 2019: 53.8%FY 2020: 31.3%FY 2021: 55.6%FY 2022: 50.3%FY 2023: 52.2%FY 2024: 54.4%FY 2025: 48.1%
FY 2016 5y median 52.2% FY 2025
Net Margin 38.1%
FY 2016: -45.8%FY 2017: 42.8%FY 2018: 51.9%FY 2019: 58.4%FY 2020: 51.1%FY 2021: 51.5%FY 2022: 31.8%FY 2023: 39.1%FY 2024: 40.4%FY 2025: 38.1%
FY 2016 5y median 39.1% FY 2025
ROE 15.0%
FY 2016: -17.5%FY 2017: 28.3%FY 2018: 33.6%FY 2019: 31.7%FY 2020: 23.1%FY 2021: 25.0%FY 2022: 16.6%FY 2023: 18.6%FY 2024: 17.6%FY 2025: 15.0%
FY 2016 5y median 17.6% FY 2025
ROIC 13.1%
FY 2016: -16.0%FY 2017: 26.7%FY 2018: 31.2%FY 2019: 29.1%FY 2020: 13.9%FY 2021: 25.6%FY 2022: 15.3%FY 2023: 16.2%FY 2024: 16.4%FY 2025: 13.1%
FY 2016 5y median 16.2% FY 2025
ROA 13.3%
FY 2016: -15.5%FY 2017: 25.1%FY 2018: 30.8%FY 2019: 29.1%FY 2020: 20.4%FY 2021: 22.8%FY 2022: 14.4%FY 2023: 15.7%FY 2024: 15.4%FY 2025: 13.3%
FY 2016 5y median 15.4% FY 2025

Growth (YoY)

Revenue 7.8%
FY 2016: 105.6%FY 2017: 145.8%FY 2018: 52.0%FY 2019: 21.8%FY 2020: 4.9%FY 2021: 47.3%FY 2022: 37.0%FY 2023: 19.2%FY 2024: 12.6%FY 2025: 7.8%
FY 2016 FY 2025
Operating Income -4.7%
FY 2016: 67.2%FY 2017: 291.5%FY 2018: 79.6%FY 2019: 36.6%FY 2020: -38.9%FY 2021: 161.8%FY 2022: 23.9%FY 2023: 23.7%FY 2024: 17.3%FY 2025: -4.7%
FY 2016 FY 2025
EPS (diluted) 2.9%
FY 2016: 71.3%FY 2017: 303.2%FY 2018: 92.9%FY 2019: 37.0%FY 2020: -18.9%FY 2021: 60.0%FY 2022: -16.7%FY 2023: 47.5%FY 2024: 18.6%FY 2025: 2.9%
FY 2016 FY 2025
Free Cash Flow 29.6%
FY 2016: -13.1%FY 2017: 291.8%FY 2018: 18.0%FY 2019: 56.6%FY 2020: -26.9%FY 2021: 38.4%FY 2022: 114.2%FY 2023: -9.0%FY 2024: -12.3%FY 2025: 29.6%
FY 2016 FY 2025

Financial Health

Current Ratio 9.7×
FY 2016: 8.7×FY 2017: 9.0×FY 2018: 12.2×FY 2019: 12.3×FY 2020: 9.1×FY 2021: 11.8×FY 2022: 10.2×FY 2023: 7.4×FY 2024: 8.8×FY 2025: 9.7×
FY 2016 5y median 9.7× FY 2025
Quick Ratio 9.3×
FY 2016: 8.3×FY 2017: 8.7×FY 2018: 12.0×FY 2019: 11.9×FY 2020: 8.9×FY 2021: 11.4×FY 2022: 10.1×FY 2023: 7.1×FY 2024: 8.4×FY 2025: 9.3×
FY 2016 5y median 9.3× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -3.9×
FY 2016: 3.3×FY 2017: -3.5×FY 2018: -3.0×FY 2019: -3.2×FY 2020: -2.3×FY 2021: -1.3×FY 2022: -0.8×FY 2023: -0.5×FY 2024: -3.3×FY 2025: -3.9×
FY 2016 5y median -1.3× FY 2025
Interest Coverage 10.2×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 791×FY 2020: 394×FY 2021: 16.5×FY 2022: 14.5×FY 2023: 12.8×FY 2024: 10.8×FY 2025: 10.2×
FY 2016 5y median 12.8× FY 2025

Dividends

Dividend Yield 0.5%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.1%FY 2020: 0.1%FY 2021: 0.1%FY 2022: 0.2%FY 2023: 0.2%FY 2024: 0.3%FY 2025: 0.5%
FY 2016 5y median 0.2% FY 2025
Payout Ratio 6.9%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 5.3%FY 2020: 7.4%FY 2021: 5.0%FY 2022: 5.9%FY 2023: 6.5%FY 2024: 6.9%FY 2025: 6.9%
FY 2016 5y median 6.5% FY 2025

Annual · latest fiscal year ends 2025-06-30